Edwards Lifesciences (EW) — insider trading
Health Care · NYSE
Edwards Lifesciences (EW) has 136 reported SEC Form 4 insider transactions in our data, including 23 open-market sales among the most recent 100 (latest 2026-10-08).
Recent Form 4 transactions
Showing the 100 most recent of 136 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 619 | — | $0 | Form 4 |
| 2026-10-08 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 619 | $85.65 | $53.0K | Form 4 |
| 2026-10-08 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 619 | $72.68 | $45.0K | Form 4 |
| 2026-09-14 | Markowitz Wayne | Officer (CVP, JAPAC) | Shares withheld for taxes / exercise cost | 568 | $84.37 | $47.9K | Form 4 |
| 2026-09-13 | Dahl Andrew M. | Officer (SVP, Corporate Controller) | Shares withheld for taxes / exercise cost | 253 | $84.37 | $21.3K | Form 4 |
| 2026-09-11 | Markowitz Wayne | Officer (CVP, JAPAC) | Shares withheld for taxes / exercise cost | 355 | $86.77 | $30.8K | Form 4 |
| 2026-09-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 619 | — | $0 | Form 4 |
| 2026-09-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 619 | $87.51 | $54.2K | Form 4 |
| 2026-09-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 619 | $72.68 | $45.0K | Form 4 |
| 2026-09-11 | Chopra Daveen | Officer (CVP, TMTT, Surgical & IHFM) | Shares withheld for taxes / exercise cost | 398 | $86.77 | $34.5K | Form 4 |
| 2026-08-31 | Dahl Andrew M. | Officer (SVP, Corporate Controller) | Open-market sale | 544 | $91.06 | $49.5K | Form 4 |
| 2026-08-28 | Bruls Annette | Officer (CVP, EMEACLA) | Open-market sale | 2,644 | $89.98 | $237.9K | Form 4 |
| 2026-08-26 | Markowitz Wayne | Officer (CVP, JAPAC) | Open-market sale | 1,240 | $91.47 | $113.4K | Form 4 |
| 2026-08-26 | Chopra Daveen | Officer (CVP, TMTT, Surgical & IHFM) | Option exercise / conversion (derivative) | 31,800 | — | $0 | Form 4 |
| 2026-08-26 | Chopra Daveen | Officer (CVP, TMTT, Surgical & IHFM) | Open-market sale | 30,646 | $90.99 | $2.79M | Form 4 |
| 2026-08-26 | Chopra Daveen | Officer (CVP, TMTT, Surgical & IHFM) | Open-market sale | 1,154 | $91.76 | $105.9K | Form 4 |
| 2026-08-26 | Chopra Daveen | Officer (CVP, TMTT, Surgical & IHFM) | Option exercise / conversion | 31,800 | $72.68 | $2.31M | Form 4 |
| 2026-08-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 619 | — | $0 | Form 4 |
| 2026-08-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 619 | $92.03 | $57.0K | Form 4 |
| 2026-08-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 619 | $72.68 | $45.0K | Form 4 |
| 2026-07-30 | Markowitz Wayne | Officer (CVP, JAPAC) | Open-market sale | 146 | $86.03 | $12.6K | Form 4 |
| 2026-07-28 | Markowitz Wayne | Officer (CVP, JAPAC) | Option exercise / conversion (derivative) | 9,628 | — | $0 | Form 4 |
| 2026-07-28 | Markowitz Wayne | Officer (CVP, JAPAC) | Open-market sale | 9,628 | $85.06 | $819.0K | Form 4 |
| 2026-07-28 | Markowitz Wayne | Officer (CVP, JAPAC) | Option exercise / conversion | 9,628 | $74.02 | $712.7K | Form 4 |
| 2026-07-27 | Zovighian Bernard J | Director, Officer (CEO) | Open-market sale | 2,921 | $83.93 | $245.1K | Form 4 |
| 2026-07-27 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 320 | — | $0 | Form 4 |
| 2026-07-27 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 320 | — | $0 | Form 4 |
| 2026-07-11 | Bruls Annette | Officer (CVP, EMEACLA) | Shares withheld for taxes / exercise cost | 109 | $92.21 | $10.1K | Form 4 |
| 2026-07-10 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 619 | — | $0 | Form 4 |
| 2026-07-10 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 619 | $91.70 | $56.8K | Form 4 |
| 2026-07-10 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 619 | $72.68 | $45.0K | Form 4 |
| 2026-07-09 | Mistras Theodora | Officer (CVP, Chief Financial Officer) | Grant / award / vesting (derivative) | 12,325 | — | $0 | Form 4 |
| 2026-07-09 | Mistras Theodora | Officer (CVP, Chief Financial Officer) | Grant / award / vesting (derivative) | 61,800 | — | $0 | Form 4 |
| 2026-07-09 | Mistras Theodora | Officer (CVP, Chief Financial Officer) | Grant / award / vesting | 12,325 | — | $0 | Form 4 |
| 2026-07-09 | Mistras Theodora | Officer (CVP, Chief Financial Officer) | Grant / award / vesting | 87,595 | — | $0 | Form 4 |
| 2026-07-07 | Lippis Daniel J. | Officer (CVP, TAVR) | Shares withheld for taxes / exercise cost | 377 | $95.18 | $35.9K | Form 4 |
| 2026-06-30 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 619 | — | $0 | Form 4 |
| 2026-06-30 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 619 | $91.40 | $56.6K | Form 4 |
| 2026-06-30 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 619 | $72.68 | $45.0K | Form 4 |
| 2026-06-17 | Zovighian Bernard J | Director, Officer (CEO) | Open-market sale | 523 | $87.92 | $46.0K | Form 4 |
| 2026-05-29 | Dahl Andrew M. | Officer (SVP, Corporate Controller) | Open-market sale | 568 | $86.08 | $48.9K | Form 4 |
| 2026-05-27 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Open-market sale | 23,145 | $86.42 | $2.00M | Form 4 |
| 2026-05-22 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Open-market sale | 1,500 | $84.60 | $126.9K | Form 4 |
| 2026-05-18 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion (derivative) | 620 | — | $0 | Form 4 |
| 2026-05-18 | Lippis Daniel J. | Officer (CVP, TAVR) | Open-market sale | 620 | $81.14 | $50.3K | Form 4 |
| 2026-05-18 | Lippis Daniel J. | Officer (CVP, TAVR) | Option exercise / conversion | 620 | $72.68 | $45.1K | Form 4 |
| 2026-05-15 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Open-market sale | 8,000 | $81.82 | $654.6K | Form 4 |
| 2026-05-15 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Open-market sale | 9,968 | $82.07 | $818.1K | Form 4 |
| 2026-05-12 | Zovighian Bernard J | Director, Officer (CEO) | Open-market sale | 35,506 | $77.92 | $2.77M | Form 4 |
| 2026-05-12 | Zovighian Bernard J | Director, Officer (CEO) | Open-market sale | 845 | $78.40 | $66.3K | Form 4 |
| 2026-05-12 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 26,640 | — | $0 | Form 4 |
| 2026-05-12 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 26,640 | — | $0 | Form 4 |
| 2026-05-11 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Option exercise / conversion (derivative) | 13,583 | — | $0 | Form 4 |
| 2026-05-11 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Shares withheld for taxes / exercise cost | 7,538 | $79.96 | $602.7K | Form 4 |
| 2026-05-11 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Option exercise / conversion | 13,583 | — | $0 | Form 4 |
| 2026-05-11 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Option exercise / conversion (derivative) | 13,457 | — | $0 | Form 4 |
| 2026-05-11 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Shares withheld for taxes / exercise cost | 7,469 | $79.96 | $597.2K | Form 4 |
| 2026-05-11 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Option exercise / conversion | 13,457 | — | $0 | Form 4 |
| 2026-05-11 | Zovighian Bernard J | Director, Officer (CEO) | Option exercise / conversion (derivative) | 47,207 | — | $0 | Form 4 |
| 2026-05-11 | Zovighian Bernard J | Director, Officer (CEO) | Shares withheld for taxes / exercise cost | 26,198 | $79.96 | $2.09M | Form 4 |
| 2026-05-11 | Zovighian Bernard J | Director, Officer (CEO) | Option exercise / conversion | 47,207 | — | $0 | Form 4 |
| 2026-05-11 | Lippis Daniel J. | Officer (CVP, TAVR) | Shares withheld for taxes / exercise cost | 362 | $79.96 | $28.9K | Form 4 |
| 2026-05-11 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 5,489 | — | $0 | Form 4 |
| 2026-05-11 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 5,489 | — | $0 | Form 4 |
| 2026-05-11 | Markowitz Wayne | Officer (CVP, JAPAC) | Open-market sale | 593 | $79.73 | $47.3K | Form 4 |
| 2026-05-11 | Ullem Scott B. | Officer (CVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 19,830 | — | $0 | Form 4 |
| 2026-05-11 | Ullem Scott B. | Officer (CVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 11,004 | $79.96 | $879.9K | Form 4 |
| 2026-05-11 | Ullem Scott B. | Officer (CVP, Chief Financial Officer) | Option exercise / conversion | 19,830 | — | $0 | Form 4 |
| 2026-05-08 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 4,222 | — | $0 | Form 4 |
| 2026-05-08 | Zovighian Bernard J | Director, Officer (CEO) | Shares withheld for taxes / exercise cost | 5,398 | $82.76 | $446.7K | Form 4 |
| 2026-05-08 | Zovighian Bernard J | Director, Officer (CEO) | Bona fide gift | 4,222 | — | $0 | Form 4 |
| 2026-05-08 | Markowitz Wayne | Officer (CVP, JAPAC) | Shares withheld for taxes / exercise cost | 226 | $82.76 | $18.7K | Form 4 |
| 2026-05-08 | Bruls Annette | Officer (CVP, EMEACLA) | Shares withheld for taxes / exercise cost | 84 | $82.76 | $7.0K | Form 4 |
| 2026-05-08 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Shares withheld for taxes / exercise cost | 1,141 | $82.76 | $94.4K | Form 4 |
| 2026-05-08 | Dahl Andrew M. | Officer (SVP, Corporate Controller) | Shares withheld for taxes / exercise cost | 289 | $82.76 | $23.9K | Form 4 |
| 2026-05-08 | Lippis Daniel J. | Officer (CVP, TAVR) | Shares withheld for taxes / exercise cost | 450 | $82.76 | $37.2K | Form 4 |
| 2026-05-08 | Davis Leslie C. | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | Ullem Scott B. | Officer (CVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,661 | $82.76 | $137.5K | Form 4 |
| 2026-05-08 | BOBO DONALD E JR | Officer (CVP,Strategy/Corp Development) | Shares withheld for taxes / exercise cost | 1,038 | $82.76 | $85.9K | Form 4 |
| 2026-05-08 | Feinberg David T | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | GALLAHUE KIERAN | Director | Grant / award / vesting | 1,064 | — | $0 | Form 4 |
| 2026-05-08 | GALLAHUE KIERAN | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | STONE HEISZ LESLIE | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | LAVIOLETTE PAUL A | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | LORANGER STEVEN R | Director | Grant / award / vesting | 1,064 | — | $0 | Form 4 |
| 2026-05-08 | LORANGER STEVEN R | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | Sequeira Ramona | Director | Grant / award / vesting | 3,251 | — | $0 | Form 4 |
| 2026-05-08 | VALERIANI NICHOLAS J | Director | Grant / award / vesting | 5,127 | — | $0 | Form 4 |
| 2026-05-07 | Zovighian Bernard J | Director, Officer (CEO) | Grant / award / vesting (derivative) | 43,800 | — | $0 | Form 4 |
| 2026-05-07 | Zovighian Bernard J | Director, Officer (CEO) | Grant / award / vesting (derivative) | 245,300 | — | $0 | Form 4 |
| 2026-05-07 | Zovighian Bernard J | Director, Officer (CEO) | Shares withheld for taxes / exercise cost | 4,153 | $83.20 | $345.5K | Form 4 |
| 2026-05-07 | Zovighian Bernard J | Director, Officer (CEO) | Grant / award / vesting | 43,800 | — | $0 | Form 4 |
| 2026-05-07 | Markowitz Wayne | Officer (CVP, JAPAC) | Grant / award / vesting (derivative) | 5,200 | — | $0 | Form 4 |
| 2026-05-07 | Markowitz Wayne | Officer (CVP, JAPAC) | Grant / award / vesting (derivative) | 26,400 | — | $0 | Form 4 |
| 2026-05-07 | Markowitz Wayne | Officer (CVP, JAPAC) | Shares withheld for taxes / exercise cost | 264 | $83.20 | $22.0K | Form 4 |
| 2026-05-07 | Markowitz Wayne | Officer (CVP, JAPAC) | Grant / award / vesting | 5,200 | — | $0 | Form 4 |
| 2026-05-07 | Bruls Annette | Officer (CVP, EMEACLA) | Grant / award / vesting (derivative) | 6,650 | — | $0 | Form 4 |
| 2026-05-07 | Bruls Annette | Officer (CVP, EMEACLA) | Grant / award / vesting (derivative) | 33,700 | — | $0 | Form 4 |
| 2026-05-07 | Bruls Annette | Officer (CVP, EMEACLA) | Grant / award / vesting | 6,650 | — | $0 | Form 4 |
| 2026-05-07 | Chopra Daveen | Officer (CVP, TMTT & Surgical) | Grant / award / vesting (derivative) | 9,675 | — | $0 | Form 4 |
Ask the chat about EW's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Edwards Lifesciences (EW).
Last updated 2026-10-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.